【🧬Advancing the Path from Genomic Discovery to Patient Impact at CARE Summit 2026 🌏】 How can we accelerate the journey from scientific discovery to real-world patient impact? 🧬✨ This was one of the key themes explored at CARE Summit 2026, which brought together healthcare, research and innovation leaders from around the world to exchange ideas on advancing patient care and medical innovation. HKGI was honoured to contribute to these conversations by hosting the pre-conference symposium, titled “Advanced Therapies and Genomic-Informed Treatment: A Global Perspective from Bench to Clinical Trial”, and participating in the Summit's opening ceremony. 🤝🔬 Opening the symposium, our CEO, Dr Hon-Yin Brian Chung, highlighted the transformative potential of genomic medicine and innovative therapies, and the importance of strengthening the research and clinical ecosystems needed to bring these advances to patients. We were privileged to hear from Prof 𝗞𝗵𝘂𝗹𝗼𝘂𝗱 𝗔𝗹-𝗝𝗮𝗺𝗮𝗹 of HKUMed – The University of Hong Kong, Dr 𝗚𝗿𝗲𝗴𝗼𝗿𝘆 𝗖𝗼𝘀𝘁𝗮𝗶𝗻 of The Hospital for Sick Children (SickKids) and University of Toronto, and Prof 𝗔𝗻𝗱𝗿𝗲𝘄 𝗗𝗮𝘃𝗶𝗱𝘀𝗼𝗻 of the 𝗠𝗲𝗹𝗯𝗼𝘂𝗿𝗻𝗲 𝗖𝗵𝗶𝗹𝗱𝗿𝗲𝗻'𝘀 𝗧𝗿𝗶𝗮𝗹𝘀 𝗖𝗲𝗻𝘁𝗿𝗲, whose presentations showcased international efforts to advance innovative therapies, personalised genetic medicines and collaborative clinical trial networks. 🌐🩺 The discussion continued in a panel session moderated by Dr Chung, featuring Prof 𝗕𝗲𝗿𝗻𝗮𝗿𝗱 𝗖𝗵𝗲𝘂𝗻𝗴, CEO of Greater Bay Area International Clinical Trial Institute (GBAICTI), Dr David M Collier 康德維, a life sciences consultant, and the symposium speakers. Together, they explored how collaboration across research, healthcare, policy and clinical trials can help translate scientific breakthroughs into meaningful patient benefit. Insights were also drawn from the interactive discussion between panellists and the audience. We extend our sincere thanks to all speakers, panellists and participants for contributing to an inspiring exchange of ideas. As genomic medicine and innovative therapies continue to evolve, HKGI looks forward to working with partners locally and globally to help turn scientific breakthroughs into better outcomes for patients. 🚀🌏🧬 {hashtag|#|HKGI} {hashtag|#|HongKongGenomeInstitute} {hashtag|#|CARESummit2026} {hashtag|#|GenomicMedicine} {hashtag|#|PrecisionMedicine} {hashtag|#|AdvancedTherapies} {hashtag|#|ClinicalTrials} {hashtag|#|HealthcareInnovation}

【✨Register Now! HKGI Session at CARE Summit 2026】 How can advances in genomic medicine translate into new treatments for rare diseases? 💡 Join HKGI’s dedicated 𝗧𝗿𝗮𝗰𝗸 𝟮 session, themed “𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗮𝗻𝗱 𝗚𝗲𝗻𝗼𝗺𝗶𝗰-𝗜𝗻𝗳𝗼𝗿𝗺𝗲𝗱 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁: 𝗔 𝗚𝗹𝗼𝗯𝗮𝗹 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝗳𝗿𝗼𝗺 𝗕𝗲𝗻𝗰𝗵 𝘁𝗼 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹”, at CARE Summit 2026. Distinguished experts from around the world will share insights into genetic medicines, precision child health and the role of clinical trial networks in advancing novel therapies for rare and genetic diseases. Join the conversation and explore ways to bring innovative therapies closer to patients. 🌍💬 📅 Date & Time: 4 November 2026 | 2:00–5:15 pm (HKT) 📍 Venue: S420 Series Rooms, Level 4, Hong Kong Convention and Exhibition Centre, Wan Chai, Hong Kong 🎟️Admission & Format: Free admission | Physical attendance (first come, first served) 🔗 Join Us Now: https://lnkd.in/gg7fkg\_M {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeInstitute} {hashtag|#|GenomicMedicine} {hashtag|#|GenomeProject} {hashtag|#|CARESummit2026} {hashtag|#|Conference} {hashtag|#|ClinicalTrials}

【Celebrating Nursing Leadership and Shared Learning 🎊】   An inspiring evening of celebration, connection and shared commitment to nurturing healthcare leaders!   HKGI was delighted to attend the HKU JC Nursing Leadership Development Fellowship (NLDF) Alumni Association Graduation Banquet, joining nearly 100 healthcare professionals, alumni and guests to celebrate the Fellows’ achievements. 🎓   Led by Prof Sophia Siu Chee CHAN, Director of the HKU JC NLDF Programme, the Fellowship empowers nursing leaders to broaden their vision, embrace greater possibilities and shape the future of healthcare. In her remarks, Prof Chan highlighted the Programme’s mission and the importance of cultivating the next generation of healthcare leaders. Her message underscored the evening’s spirit of shared learning and lasting connection.   Our CEO, Dr Hon-Yin Brian Chung, also delivered a guest lecture on “Genetic and Genomic Development in Hong Kong”, supporting knowledge exchange across disciplines. It was a meaningful opportunity to bring genomic perspectives into the conversation on healthcare leadership.   Congratulations to all the graduating Fellows! 🎉   {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeProject} {hashtag|#|GenomicMedicine} {hashtag|#|NursingLeadership} {hashtag|#|HealthcareLeadership} {hashtag|#|NurtureTalents}

【Blood-Based Protein Biomarkers for Alzheimer’s Disease: Diagnostic and Mechanistic Insights】   To connect medical professionals in genetics and genomics, we have been organising a series of thematic seminars under the GENE Club — a platform for clinicians, scientists, and researchers to exchange knowledge, foster collaboration, and nurture excellence in genomic medicine.   In the latest session, we were delighted to welcome Prof Amy Fu Kit-yu, who explored how blood-based biomarkers and artificial intelligence are opening new possibilities for earlier detection, disease staging and treatment monitoring in Alzheimer’s disease. 🧪   🎤 Topic: Blood-Based Protein Biomarkers for Alzheimer’s Disease: Diagnostic and Mechanistic Insights 👩🏻‍⚕️Speakers: Prof Amy Fu Kit-yu Research Professor, Division of Life Science, The Hong Kong University of Science and Technology 📽️ Watch the seminar here: https://lnkd.in/g5fNZZBs   {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeInstitute} {hashtag|#|GenomicMedicine} {hashtag|#|GenomeProject} {hashtag|#|GENEClub} {hashtag|#|KnowledgeSharing} {hashtag|#|AlzheimersDisease} {hashtag|#|Biomarkers} {hashtag|#|ArtificialIntelligence}

【Behind the Green Level: HKGI's Green Lab Certificate🌱🔬】   Every sustainable lab starts with everyday actions. 👩🏻‍🔬✨   Building on our earlier sharing, we are excited to share that HKGI’s genomic laboratory has achieved the Green Level of the internationally recognised My Green Lab Certification programme, which is the highest-tier and most prestigious ranking in the programme. 🎉   To mark this achievement, we have created a video showcasing how sustainability is embedded in our daily laboratory operations, from smart inventory management and waste reduction to resource conservation and other everyday green practices.   These small but meaningful actions reflect our ongoing efforts to create a more sustainable laboratory environment.   Watch the video to learn more about the efforts behind our green lab journey. 💚   {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|MyGreenLab} {hashtag|#|Sustainability} {hashtag|#|SustainableScience} {hashtag|#|GenomicMedicine} {hashtag|#|ScientificResearch}

【HKGI-APSHG Distinguished Scholar Lectures: The Presidential Series | Developing Drugs to Target RNA Splice Mutations】   Could the next breakthrough in genomic medicine lie in targeting RNA splice mutations? 🧬✨   Organised in partnership with the Asia Pacific Society of Human Genetics (APSHG), the series brings together presidents of leading human genetics societies worldwide to share leadership perspectives and international developments shaping the future of genomic medicine. 🌟   For the fourth lecture, we are pleased to welcome Prof Susan A. Slaugenhaupt, PhD, President of The American Society of Human Genetics, who will speak on “Developing Drugs to Target RNA Splice Mutations”, exploring how new medicines are being developed to tackle RNA splicing mutations in genetic diseases.   🗣️ Speaker: Prof Susan A. Slaugenhaupt, PhD, President, The American Society of Human Genetics 🎤 Lecture Topic: Developing Drugs to Target RNA Splice Mutations 📅 Date: 28 Oct 2026 (Wed) | Time: 8:00-9:00pm (HKT) 🔗 Register now: https://lnkd.in/gerckiGU   Join us for this insightful session!   ✅  𝐂𝐌𝐄 𝐚𝐜𝐜𝐫𝐞𝐝𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐟𝐢𝐫𝐦𝐞𝐝 𝐛𝐲 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐏𝐬𝐲𝐜𝐡𝐢𝐚𝐭𝐫𝐢𝐬𝐭𝐬, 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐑𝐚𝐝𝐢𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐨𝐮𝐧𝐜𝐢𝐥 𝐨𝐟 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠, 𝐓𝐡𝐞 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐎𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬 𝐨𝐟 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠, 𝐓𝐡𝐞 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐒𝐮𝐫𝐠𝐞𝐨𝐧𝐬 𝐨𝐟 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐀𝐧𝐚𝐞𝐬𝐭𝐡𝐞𝐬𝐢𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐄𝐦𝐞𝐫𝐠𝐞𝐧𝐜𝐲 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐅𝐚𝐦𝐢𝐥𝐲 𝐏𝐡𝐲𝐬𝐢𝐜𝐢𝐚𝐧𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐎𝐛𝐬𝐭𝐞𝐭𝐫𝐢𝐜𝐢𝐚𝐧𝐬 𝐚𝐧𝐝 𝐆𝐲𝐧𝐚𝐞𝐜𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐎𝐫𝐭𝐡𝐨𝐩𝐚𝐞𝐝𝐢𝐜 𝐒𝐮𝐫𝐠𝐞𝐨𝐧𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐎𝐭𝐨𝐫𝐡𝐢𝐧𝐨𝐥𝐚𝐫𝐲𝐧𝐠𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐏𝐚𝐞𝐝𝐢𝐚𝐭𝐫𝐢𝐜𝐢𝐚𝐧𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐢𝐬𝐭𝐬, 𝐓𝐡𝐞 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐏𝐡𝐲𝐬𝐢𝐜𝐢𝐚𝐧𝐬; 𝐚𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥𝐬 𝐚𝐫𝐞 𝐩𝐞𝐧𝐝𝐢𝐧𝐠.   {hashtag|#|HKGI} {hashtag|#|HKGP} {hashtag|#|HongKongGenomeProject} {hashtag|#|GenomicMedicine} {hashtag|#|APSHG} {hashtag|#|PresidentialSeries} {hashtag|#|DrugDevelopment} {hashtag|#|GeneticDiseases} {hashtag|#|HumanGenetics}